Beactica Therapeutics AB

Showing: 1 - 1 of 1 Articles

Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate

Beactica Therapeutics AB, the Swedish precision oncology company, today announced the selection of BEA-17 as …